Effect of Cognitive Behavioral therapy on depression reduction and medication adherence among people living with HIV/AIDS

A Randomized Controlled Trial of Cognitive Behavioral Therapy Outcome for Adherence and Depression (CBT-AD) among people living with HIV/AIDS who have been on Anti Retro viral therapy (ART) follow up at Jimma University Medical Center (JUMC) 2017/018

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR201910542343192

Enrollment

283

Registered

2019-10-17

Start date

2017-10-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS Mental and Behavioural Disorders

Interventions

Cognitive Behavioral Therapy and Drug Adherence

Non cognitive Behavioral Therapy and drug adherence therapy group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: • Age 18 and above • People living with HIV/AIDS (PLWHA) who are on ART medication • Mild to moderate depression (BDI-II score of 14 to 28) • PLWHA on ART follow up for at least four months

Exclusion criteria

Exclusion criteria: Age below 18 • People living with HIV/AIDS (PLWHA) who are not on ART medication • Severe depression (BDI-II score of 29 and above) • PLWHA on ART follow up for less than three months

Design outcomes

Primary

Measure	Time frame
Depression symptom, ART drug adherence improvement	—

Secondary

Measure	Time frame
perceived stigma, Sleep quality	—

Countries

Ethiopia

Contacts

Public ContactHabtamu Kerebih

Assistant Professor at University of Gonder

habtishk@gmail.com+25124316221

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026